Mono Pharmacare Share Price
₹34.65 +1.65 (5%)
28 Dec, 2024 02:29
Start SIP in MONOPHARMA
Start SIPPerformance
- Low
- ₹34
- High
- ₹35
- 52 Week Low
- ₹32
- 52 Week High
- ₹75
- Open Price₹34
- Previous Close₹33
- Volume8,000
Investment Returns
- Over 1 Month -1%
- Over 3 Month -15.07%
- Over 6 Month -10.7%
- Over 1 Year -30.35%
Smart Investing Starts Here Start SIP with Mono Pharmacare for Steady Growth!
Mono Pharmacare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -
- PEG Ratio
- -
- Market Cap Cr
- 61
- P/B Ratio
- 2.2
- Average True Range
- 1.32
- EPS
- 1.38
- Dividend Yield
- 0
- MACD Signal
- -0.48
- RSI
- 50.17
- MFI
- 45.59
Mono Pharmacare Financials
Mono Pharmacare Technicals
EMA & SMA
Current Price
₹34.65
+
1.65
(5%)
- Bullish Moving Average 8
- Bearish Moving Average 8
- 20 Day
- ₹34.34
- 50 Day
- ₹35.54
- 100 Day
- ₹37.74
- 200 Day
- ₹41.60
Resistance and Support
34.58
- R3 34.92
- R2 34.78
- R1 34.72
- S1 34.52
- S2 34.38
- S3 34.32
Mono Pharmacare Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-14 | Quarterly Results & Others | To consider other business matters. |
2024-08-06 | Others | To take note of resignation of Mrs. Pooja Seth as Company Secretary and Compliance Officer of the Company and other business matters. |
2024-04-29 | Others | To consider other business matters |
Mono Pharmacare F&O
About Mono Pharmacare
- NSE Symbol
- MONOPHARMA
- BSE Symbol
- Managing Director
- Mr. Panilam Lakhatariya
- ISIN
- INE0OIP01012
Similar Stocks to Mono Pharmacare
Mono Pharmacare FAQs
Mono Pharmacare share price is ₹34 As on 28 December, 2024 | 02:15
The Market Cap of Mono Pharmacare is ₹61.2 Cr As on 28 December, 2024 | 02:15
The P/E ratio of Mono Pharmacare is As on 28 December, 2024 | 02:15
The PB ratio of Mono Pharmacare is 2.2 As on 28 December, 2024 | 02:15
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.